David Yoder, Ph.D., is a Senior Manager of Product Strategy at Aldevron’s Madison, Wisconsin, facility, with a focus on CRISPR products and services. With a doctorate in Molecular Biology from the University of North Texas, David manages a portfolio of cutting-edge CRISPR technology to help scientists rapidly advance cell and gene therapies by providing high-tech tools to generate engineered cells. He has a broad molecular background with prior work at Promega, Thermo Fisher, and Synthego.
Also Speaking
Craig Hasilo
19 November 2022
Leonardo M.R. Ferreira
Assistant Professor of Microbiology and Immunology • Medical University of South Carolina
8 January 2023
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023